查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2049525

質譜市場規模、佔有率、趨勢和預測：按技術、應用和地區分類，2026-2034年

Mass Spectrometry Market Size, Share, Trends and Forecast by Technology, Application, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3個工作天內

價格

2025年全球質譜市場規模為73億美元。預計到2034年，該市場規模將達到120億美元，2026年至2034年的複合年成長率（CAGR）為5.50%。目前，北美市場佔據主導地位，預計2025年將佔據約41.7%的市場。推動該市場成長的主要因素是製藥、生物技術和食品安全產業對準確、快速分析方法的需求。此外，藥物研發投入的增加以及慢性病發病率的上升，正在加速質譜技術在蛋白質體學、代謝體學和臨床診斷領域的應用。同時，混合光譜技術和自動化技術的進步也提升了儀器的功能，進一步擴大了質譜市場佔有率。

高解析度儀器的持續進步和電離技術的改進對該市場產生了顯著影響，並推動了其在各行業的應用。此外，人們對環境污染和微量檢測的日益關注也加速了其在食品檢測和水質監測中的應用。 2025年1月發布的一份研究報告強調了質譜技術（包括GC-MS、LC-MS/MS和高解析度混合系統）在水、土壤和空氣基質中新型環境污染物微量監測中的關鍵作用。研究報告稱，水中藥物殘留的檢測極限極低，僅1.13–5.45 ng L⁻¹，凸顯了高解析度平台實現的即時檢測和非靶向篩檢揮發性有機化合物的重要性。此外，藥物研發管線的擴展和生物製藥研究的蓬勃發展也推動了對精確分子表徵的需求，進一步促進了該市場的發展。

在美國，對個人化醫療和基因研究的日益重視正在推動市場發展，並增加對精細分子分析工具的需求。此外，質譜市場的一個新趨勢是聯邦政府對生物醫學和臨床研究的大量資助，這為儀器的重大升級提供了支持。產業報告顯示，美國國立衛生研究院 (NIH) 每年投資超過 470 億美元，使其成為全球最大的健康、醫學和行為科學研究公共資助機構。食品標示和農藥殘留的嚴格法規也推動了農業和食品檢測實驗室對質譜技術的應用。此外，先進法醫學鑑定方案的製定和國防安全保障的加強也迫使各機構採用高精度檢測設備。質譜技術與代謝體學和脂類組學工作流程的整合也深化了相關研究。最後，領先製造商的強大實力和便利的技術支援正在推動美國各地實驗室的持續投資。

質譜市場發展趨勢：

技術進步

持續的技術進步顯著推動了市場成長。靈敏度、精度和處理速度等尖端技術的提升，使這些儀器成為現代實驗室不可或缺的設備。此外，技術進步拓展了質譜儀的功能，使其能夠分析日益複雜的樣品。同時，高解析度質譜和串聯式質譜質譜等最新創新技術，提供了前所未有的細節和深度分析，進一步促進了市場成長。即時監測功能的加入，實現了數據的即時採集和解讀，推動了質譜市場的發展。此外，儀器的微型化催生了可用於現場分析的攜帶式設備，進一步推動了市場發展。在此背景下，2025年3月，908 Devices公司從烏克蘭衛生署獲得了一份價值170萬美元的MX908手持式質譜儀訂單，該儀器用於戰後環境調查中危險物質和爆炸物的檢測。這凸顯了市場對攜帶式解決方案日益成長的需求。

嚴格的品管監管政策

製藥和食品安全等行業的品管監管要求正在推動市場擴張。監管機構推出的嚴格標準促使企業依賴質譜技術 (MST)，因為它具有檢測雜質、確保產品品質和檢驗製程的高精度和高靈敏度。此外，質譜技術還能確保化合物符合純度標準，並能偵測極低濃度的污染物。因此，布魯克公司於 2025 年 4 月收購了總部位於慕尼黑的臨床質譜試劑盒供應商 RECIPE 的多數股權。 RECIPE 擁有 60 名員工，年銷售額達 1,500 萬美元。此舉旨在加速開發高通量、無鉻的 ClinDART TDM 檢測方法。該技術在食品產業的廣泛應用，用於確保產品中不含農藥、毒素和其他污染物，進一步推動了市場成長。這些監管要求使得質譜技術不再只是一種選擇，而是產品開發和生產過程中品質保證的必備工具。

人們越來越關注個人化醫療

個人化醫療的日益普及是推動質譜市場前景的另一個關鍵因素。根據一份產業報告顯示，美國食品藥物管理局（FDA）已核准超過300種個人化藥物，約25%的新藥與生物標記數據相關，而個人化策略目前已佔大型製藥企業研發管線的40%以上。醫療保健正朝著為每位患者量身定做的方向發展，這導致對詳細的分子和遺傳資訊的需求日益成長。質譜技術能夠從分子層面分析生物標記、代謝物和蛋白質，從而在蛋白質體學和基因組學研究中發揮至關重要的作用。這些見解對於了解個體健康狀況、預測疾病易感性以及最佳化治療方法至關重要。此外，個人化醫療的興起正促使醫療機構和研究機構投資質譜技術，以滿足對每位患者精細資料的需求。因此，對個人化醫療的關注不僅推動了質譜技術在現有市場的應用，也使其進入了新的醫學領域。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 二手資訊
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球質譜市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依技術分類

  • 四極（串聯）
  • 四極（Q-TOF）
  • 傅立葉轉換質譜法 (FTMS)
  • 四極
  • 飛行時間（TOF）
  • 離子阱
  • 其他

第7章 市場區隔：依應用領域分類

  • 製藥
  • 生物技術
  • 化工/石油化工產品
  • 環境測試
  • 食品和飲料檢查
  • 其他

第8章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第9章 SWOT 分析

第10章：價值鏈分析

第11章：波特五力分析

第12章：價格分析

第13章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Agilent Technologies Inc.
    • Bruker
    • Danaher Corporation
    • JEOL Ltd.
    • Kore Technology Ltd.
    • LECO Corporation
    • PerkinElmer Inc.
    • Rigaku Corporation
    • Shimadzu Corporation
    • Thermo Fisher Scientific Inc.
    • Waters Corporation
Product Code: SR112026A3341

The global mass spectrometry market size was valued at USD 7.3 Billion in 2025. The market is projected to reach USD 12.0 Billion by 2034, exhibiting a CAGR of 5.50% during 2026-2034. North America currently dominates the market, holding a significant market share of around 41.7% in 2025. The market is fueled by the demand for precise and fast analytical methods in the pharmaceutical, biotechnology, and food safety industries. Moreover, increased investments in drug development and discovery, combined with the rising incidences of chronic diseases, are accelerating the adoption of mass spectrometry for proteomics, metabolomics, and clinical diagnostics. Furthermore, improvements in hybrid spectrometry technology and automation are improving instrument functionality, further augmenting the mass spectrometry market share.

The market is majorly influenced by the continuous advancements in high-resolution instrumentation and enhanced ionization techniques, which are encouraging wider use across sectors. Moreover, concerns over environmental contamination and trace-level detection have intensified deployment in food testing and water quality monitoring. A research study published in January 2025 highlights the pivotal role of mass spectrometry, including GC-MS, LC-MS/MS, and high-resolution hybrid systems, in monitoring trace levels of emerging environmental contaminants across water, soil, and air matrices. It reports detection limits as low as 1.13-5.45 ng L-1 for pharmaceutical residues in water and emphasizes real-time detection of volatile organic compounds and non-targeted screening capabilities enabled by high-resolution platforms. Also, expanding pharmaceutical pipelines and the surge in biopharmaceutical research require precise molecular characterization, further supporting demand.

In the United States, the market is driven by the growing emphasis on personalized medicine and genetic studies, which increases the requirement for detailed molecular profiling tools. Furthermore, one of the emerging mass spectrometry market trends is the substantial federal funding for biomedical and clinical research sustaining significant equipment upgrades. As per industry reports, the National Institutes of Health (NIH) invests over USD 47 Billion each year, making it the world's biggest public source of funding for research in health, medicine, and behavior. Besides, strict regulations for food labeling and pesticide residue drive adoption among agricultural and food testing labs. In addition, the development of advanced forensic protocols and heightened homeland security measures pushes agencies to acquire precise detection equipment. Also, integration of mass spectrometry into metabolomics and lipidomics workflows enhances research depth. Additionally, the robust presence of leading manufacturers and accessible technical support boosts continuous laboratory investments nationwide.

MASS SPECTROMETRY MARKET TRENDS:

Technological Advancements

Continuous technological advancements are significantly contributing to the growth of the market. Cutting-edge improvements, such as higher sensitivity, better accuracy, and rapid throughput, are making these instruments indispensable in modern laboratories. Furthermore, technological progress is expanding the capabilities of mass spectrometry instruments to include the analysis of increasingly complex samples. Additionally, recent innovations like high-resolution mass spectrometry and tandem mass spectrometry that are providing unprecedented levels of detail and analytical depth are supporting the market growth. Moreover, the incorporation of real-time monitoring capabilities, allowing immediate data collection and interpretation, is strengthening the mass spectrometry market growth. In addition, the miniaturization of these devices is leading to the creation of portable units that can be employed for on-site analysis, thereby favoring the market development. As such, in March 2025, 908 Devices received a USD 1.7 Million order from Ukraine's Ministry of Health for MX908 handheld mass spectrometers to detect hazardous substances and explosives for post-war environmental testing, highlighting the growing demand for portable solutions.

Strict Regulatory Policies for Quality Control

Regulatory requirements for quality control in industries, such as pharmaceuticals and food safety, are propelling the market expansion. The introduction of stringent standards by regulatory agencies is prompting companies to rely on mass spectrometry for its high degree of accuracy and sensitivity in detecting impurities, ensuring product quality, and validating processes. In addition, mass spectrometry ensures that compounds meet purity standards and that contaminants are detected at extremely low concentrations. Accordingly, in April 2025, Bruker acquired a majority stake in RECIPE, a Munich-based clinical MS kit provider with 60 employees and USD 15 Million revenue, advancing high-throughput 'chrom-free' ClinDART TDM assays. Furthermore, the widespread technology utilization in the food industry to ensure the absence of pesticides, toxins, and other contaminants is favoring the market growth. Moreover, these regulatory compulsions make mass spectrometry not just an option but a necessity for quality assurance in product development and manufacturing processes.

Growing Focus on Personalized Medicine

The growing emphasis on personalized medicine is another pivotal factor positively impacting the mass spectrometry market outlook. An industry report noted that the FDA approved over 300 personalized medicines, with about 25% of new drugs linked to biomarker data, and personalized strategies now make up over 40% of major pharma pipelines. Healthcare is becoming increasingly tailored to individual patients, resulting in a higher demand for detailed molecular and genetic information. Mass spectrometry provides the capability to analyze biomarkers, metabolites, and proteins at a molecular level, thereby playing a significant role in proteomics and genomics research. These insights are crucial for understanding individual health profiles, predicting disease susceptibility, and tailoring treatments accordingly. Furthermore, the rise in personalized medicine is pushing healthcare providers and research institutions to invest in mass spectrometry technologies to keep up with the demand for precise, patient-specific data. As a result, the focus on personalized healthcare is not only boosting the application of mass spectrometry in existing markets but is also pioneering its entry into new avenues of medical science.

MASS SPECTROMETRY INDUSTRY SEGMENTATION:

Analysis by Technology:

  • Triple Quadrupole (Tandem)
  • Quadrupole TOF (Q-TOF)
  • FTMS (Fourier Transform Mass Spectrometry)
  • Quadrupole
  • Time-of-Flight (TOF)
  • ION Trap
  • Others

Triple quadrupole (tandem) leads the market with around 37.5% of market share in 2025.Triple quadrupole systems offer high sensitivity and selectivity, making them ideal for detecting low-abundance analytes in complex samples. Furthermore, they are versatile and can be applied to various fields, such as proteomics, metabolomics, pharmaceuticals, and environmental analysis. This multi-disciplinary application range contributes to their widespread adoption. Besides this, triple quadrupole mass spectrometers excel in quantitative measurements, as they provide excellent repeatability and accuracy, which are crucial in sectors like drug development and diagnostics. Additionally, these systems are often compatible with various ionization techniques and chromatography systems, allowing for broader applications and easier integration into existing workflows. Moreover, triple quadrupole meets or exceeds the stringent regulations and quality standards required in many industries, which makes them a safer investment for compliance-conscious organizations.

Analysis by Application:

  • Pharmaceuticals
  • Biotechnology
  • Chemical and Petrochemicals
  • Environmental Testing
  • Food and Beverage Testing
  • Others

Pharmaceuticals lead the market in 2025. Pharmaceuticals are governed by strict regulatory standards. In line with this, mass spectrometry is invaluable for quality control and compliance, ensuring that pharmaceutical products meet these rigorous benchmarks. Furthermore, mass spectrometry is critical in the various stages of drug discovery, including target identification, screening, and pharmacokinetics. It provides accurate and precise data that aid researchers in the identification and quantification of compounds, thereby accelerating the time-to-market for new drugs. Besides this, mass spectrometry offers the high sensitivity and specificity required for proteomic and genomic studies, thereby driving its adoption in the pharmaceutical sector. Additionally, it is extensively used in metabolomics to identify and quantify metabolites, thus offering valuable insights into drug metabolism. Moreover, mass spectrometry is routinely used for quality control and batch-to-batch verification of raw materials, intermediates, and finished products.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2025, North America accounted for the largest market share of over 41.7%. North America hosts some of the world's leading research institutions and laboratories, which contributes to a high demand for mass spectrometry equipment for advanced research. Additionally, various government agencies are offering substantial grants and funding options for research and development (R&D) activities, including those that require mass spectrometry, thus fostering a favorable environment for market growth. Besides this, North America is the headquarters for numerous companies that are market leaders in the mass spectrometry segment. Moreover, the region is at the forefront of technological innovation in advanced mass spectrometry techniques like time-of-flight (TOF) and orbitrap. In addition to this, the presence of a robust healthcare system, coupled with the focus on precision medicine and diagnostics in the region, is further boosting the market growth.

KEY REGIONAL TAKEAWAYS:

UNITED STATES MASS SPECTROMETRY MARKET ANALYSIS

In 2025, the United States holds a substantial share of around 87.50% of the mass spectrometry market share in North America. The market in the United States is primarily driven by strong investments in biomedical research, which are expanding applications in precision medicine and personalized healthcare. According to the World Health Organization (WHO), approximately 88% of all biomedical research grants, amounting to nearly USD 33 Billion, were awarded to organizations based in the United States. In line with this, the rapid integration of high-resolution mass spectrometry in clinical diagnostics, which facilitates the early detection of diseases and therapeutic drug monitoring, is driving market growth. The rise in biopharmaceutical manufacturing is further propelling demand for advanced analytical systems to ensure quality control and regulatory compliance. Similarly, increasing government fundings for environmental monitoring, which encourages the widespread deployment of pollutant and toxin analysis, is fostering market expansion. The rising focus on food safety testing for contaminants and residues is driving additional market appeal. Additionally, the expansion of forensic and crime laboratories is stimulating the use of portable and high-throughput mass spectrometry solutions. Apart from this, continuous innovations in hybrid and tandem systems, which reinforces U.S. leadership in analytical research capabilities, is expanding the market scope.

EUROPE MASS SPECTROMETRY MARKET ANALYSIS

The European market is experiencing growth due to strong investments in life sciences infrastructure, supported by national and EU-level funding initiatives. In accordance with this, the growing demand for advanced analytical techniques to meet stringent EU environmental regulations is driving market expansion. Similarly, rising investment in precision medicine and oncology programs, transforming the clinical diagnostics landscape, is expanding market reach. As such, in 2024, Berlin-based AI company Aignostics raised €31.4 million in Series B funding to enhance precision medicine through AI-driven pathology insights. The round was led by ATHOS, with investments from Mayo Clinic, HTGF, and other existing investors. The heightened need for food authenticity testing and contaminant traceability driving the deployment of high-resolution systems is supporting market demand. Additionally, the emerging trend of cross-border research collaborations, which encourages the adoption of interoperable, standardized analytical platforms, is stimulating market accessibility. The rapid expansion of biopharmaceutical pipelines and biologics manufacturing hubs is driving a significant increase in the market appeal. Besides this, Europe's expanding network of accredited testing facilities and the emphasis on laboratory automation are further providing an impetus to the regional market.

ASIA PACIFIC MASS SPECTROMETRY MARKET ANALYSIS

The mass spectrometry market in the Asia Pacific is largely driven by rising government investments in precision medicine and genomic research. Furthermore, the growth of pharmaceutical manufacturing hubs in India and China, which drives demand for high-performance analytical instruments, is propelling market expansion. Similarly, increased collaborations between academic institutions and biotech companies, which foster innovation in biomarker discovery and proteomics, are strengthening market demand. The heightened adoption of stricter environmental monitoring standards is promoting the deployment of highly sensitive detection technologies. Additionally, the region's intensified focus on food safety testing is accelerating the use of mass spectrometry in the agro-food sector. Moreover, increasing funding for research and development is promoting the adoption of advanced mass spectrometry solutions in Asia Pacific healthcare and public health laboratories. Accordingly, in 2024, the National Natural Science Foundation of China (NSFC) and the U.S. NSF funded joint projects on infectious disease ecology and evolution, offering up to RMB 4.5 Million (about USD 630,000) per research project and RMB 1 Million (about USD 140,000) per exchange project, encouraging new international networks.

LATIN AMERICA MASS SPECTROMETRY MARKET ANALYSIS

In Latin America, the market is growing due to increasing government investments in public health surveillance and advanced disease diagnostics. Similarly, the expansion of precision medicine programs is driving demand for high-resolution analytical tools to support the discovery of biomarkers and the development of targeted therapies. As such, in April 2025, MGI expanded its partnership with Brazil's Fiocruz to boost epidemiological surveillance and personalized medicine, equipping UNADIG's labs with advanced sequencers to process 2,000 genetic samples weekly and 29,000 clinical samples daily. The increasing emphasis on environmental monitoring and food safety regulations is driving the deployment of advanced mass spectrometry instruments for the detection of pollutants and quality control. Furthermore, expanding collaborations between local institutions and global pharmaceutical companies are driving technology transfer, advancing innovation, and broadening the market scope.

MIDDLE EAST AND AFRICA MASS SPECTROMETRY MARKET ANALYSIS

The mass spectrometry market in the Middle East and Africa is expanding due to increasing investments in healthcare infrastructure and advanced diagnostic capabilities across leading GCC nations. Furthermore, a heightened regulatory focus on food safety and environmental monitoring is driving the adoption of high-performance mass spectrometry in laboratories and testing centers. Similarly, collaborative research partnerships between regional universities and global analytical technology providers are supporting knowledge transfer and developing local expertise. Moreover, the region's growing pharmaceutical manufacturing sector is driving demand for precise analytical tools to ensure quality control, drug safety, and compliance with international standards, thereby providing an impetus to the market. Accordingly, in May 2025, Julphar announced a five-year investment plan of AED 300 Million (about USD 81 Million) to expand manufacturing, enhance technology, and encourage UAE pharmaceutical exports to over 40 global markets.

COMPETITIVE LANDSCAPE:

The competition in the market is intense, driven by continuous technological innovations and the growing requirement for accurate, dependable analytical solutions in a variety of industries. Firms in this market concentrate on creating hybrid platforms, miniaturized instruments, and user-friendly software interfaces to improve their competitive advantage. In addition, rigorous regulatory standards and increasing demand for sophisticated analytical capability across pharmaceutical development, food safety, and environmental testing drive ongoing investment in research and development (R&D). Besides, end users now place significant value on integrated systems that deliver accurate, complex analyses with minimal manual intervention, resulting in a greater emphasis on automation and ease of operation. Also, the demand for portable and high-throughput instruments is rising, driven by laboratories seeking to improve turnaround times and cost efficiency. According to the mass spectrometry market forecast, expanding applications in personalized medicine, proteomics, and metabolomics are expected to further accelerate the need for sophisticated mass spectrometry systems.

The report provides a comprehensive analysis of the competitive landscape in the mass spectrometry market with detailed profiles of all major companies, including:

  • Agilent Technologies Inc.
  • Bruker
  • Danaher Corporation
  • JEOL Ltd.
  • Kore Technology Ltd.
  • LECO Corporation
  • PerkinElmer Inc.
  • Rigaku Corporation
  • Shimadzu Corporation
  • Thermo Fisher Scientific Inc.
  • Waters Corporation

Key Questions Answered in This Report

1. How big is the mass spectrometry market?

2. What is the future outlook of the mass spectrometry market?

3. What are the key factors driving the mass spectrometry market?

4. Which region accounts for the largest mass spectrometry market?

5. Which are the leading companies in the global mass spectrometry market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Mass Spectrometry Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Technology

  • 6.1 Triple Quadrupole (Tandem)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Quadrupole TOF (Q-TOF)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 FTMS (Fourier Transform Mass Spectrometry)
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Quadrupole
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Time-of-Flight (TOF)
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 ION Trap
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Others
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Pharmaceuticals
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Biotechnology
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Chemical and Petrochemicals
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Environmental Testing
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Food & Beverage Testing
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Agilent Technologies Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Bruker
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Danaher Corporation
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 JEOL Ltd.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Kore Technology Ltd.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 LECO Corporation
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 PerkinElmer Inc.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Rigaku Corporation
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 Shimadzu Corporation
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Thermo Fisher Scientific Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Waters Corporation
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials
      • 13.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Mass Spectrometry Market: Major Drivers and Challenges
  • Figure 2: Global: Mass Spectrometry Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Mass Spectrometry Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Mass Spectrometry Market: Breakup by Technology (in %), 2025
  • Figure 5: Global: Mass Spectrometry Market: Breakup by Application (in %), 2025
  • Figure 6: Global: Mass Spectrometry Market: Breakup by Region (in %), 2025
  • Figure 7: Global: Mass Spectrometry (Triple Quadrupole- Tandem) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 8: Global: Mass Spectrometry (Triple Quadrupole- Tandem) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 9: Global: Mass Spectrometry (Quadrupole TOF- Q-TOF) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Mass Spectrometry (Quadrupole TOF- Q-TOF) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Mass Spectrometry (FTMS- Fourier Transform Mass Spectrometry) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Mass Spectrometry (FTMS- Fourier Transform Mass Spectrometry) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Mass Spectrometry (Quadrupole) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Mass Spectrometry (Quadrupole) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Mass Spectrometry (Time-of-Flight- TOF) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Mass Spectrometry (Time-of-Flight- TOF) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Mass Spectrometry (ION Trap) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Mass Spectrometry (ION Trap) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Mass Spectrometry (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Mass Spectrometry (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Mass Spectrometry (Pharmaceuticals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Mass Spectrometry (Pharmaceuticals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Mass Spectrometry (Biotechnology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Mass Spectrometry (Biotechnology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Mass Spectrometry (Chemical and Petrochemicals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Mass Spectrometry (Chemical and Petrochemicals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Mass Spectrometry (Environmental Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Mass Spectrometry (Environmental Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Mass Spectrometry (Food & Beverage Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Mass Spectrometry (Food & Beverage Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Global: Mass Spectrometry (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Global: Mass Spectrometry (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: North America: Mass Spectrometry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: North America: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: United States: Mass Spectrometry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: United States: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Canada: Mass Spectrometry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Canada: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Asia-Pacific: Mass Spectrometry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Asia-Pacific: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: China: Mass Spectrometry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: China: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Japan: Mass Spectrometry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Japan: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: India: Mass Spectrometry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: India: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: South Korea: Mass Spectrometry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: South Korea: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Australia: Mass Spectrometry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Australia: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Indonesia: Mass Spectrometry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Indonesia: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Others: Mass Spectrometry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Others: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Europe: Mass Spectrometry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Europe: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Germany: Mass Spectrometry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Germany: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: France: Mass Spectrometry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: France: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: United Kingdom: Mass Spectrometry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: United Kingdom: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Italy: Mass Spectrometry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Italy: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Spain: Mass Spectrometry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Spain: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Russia: Mass Spectrometry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Russia: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Others: Mass Spectrometry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Others: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Latin America: Mass Spectrometry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Latin America: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Brazil: Mass Spectrometry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Brazil: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Mexico: Mass Spectrometry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: Mexico: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Others: Mass Spectrometry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 78: Others: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Middle East and Africa: Mass Spectrometry Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 80: Middle East and Africa: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 81: Middle East and Africa: Mass Spectrometry Market: Breakup by Country (in %), 2025
  • Figure 82: Global: Mass Spectrometry Industry: SWOT Analysis
  • Figure 83: Global: Mass Spectrometry Industry: Value Chain Analysis
  • Figure 84: Global: Mass Spectrometry Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Mass Spectrometry Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Mass Spectrometry Market Forecast: Breakup by Technology (in Million USD), 2026-2034
  • Table 3: Global: Mass Spectrometry Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 4: Global: Mass Spectrometry Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 5: Global: Mass Spectrometry Market: Competitive Structure
  • Table 6: Global: Mass Spectrometry Market: Key Players